Terms: = Gastric cancer AND MYCL, LMYC, 4610, MYCL1, ENSG00000116990 AND Prognosis
6 results:
1. Clinical utility of lymphocyte to C-reactive protein ratio in predicting survival and postoperative complication for esophago-gastric junction cancer.
Tsujiura M; Yamamoto A; Imaoka H; Shimura T; Kitajima T; Morimoto Y; Kawamura M; Yasuda H; Okita Y; Yokoe T; Okugawa Y; Ohi M; Toiyama Y
Surg Oncol; 2022 Sep; 44():101842. PubMed ID: 36081281
[TBL] [Abstract] [Full Text] [Related]
2. Targeted silencing of mycl1 by RNA interference inhibits migration and invasion of MGC-803 gastric cancer cells.
Qin P; Wang H; Zhang F; Huang Y; Chen S
Cell Biochem Funct; 2019 Jun; 37(4):266-272. PubMed ID: 31025404
[TBL] [Abstract] [Full Text] [Related]
3. gastric cancer stem cells: evidence, potential markers, and clinical implications.
Brungs D; Aghmesheh M; Vine KL; Becker TM; Carolan MG; Ranson M
J Gastroenterol; 2016 Apr; 51(4):313-26. PubMed ID: 26428661
[TBL] [Abstract] [Full Text] [Related]
4. Expression and prognostic value of mycl1 in gastric cancer.
Chen S; Tang J; Huang L; Lin J
Biochem Biophys Res Commun; 2015 Jan; 456(4):879-83. PubMed ID: 25528583
[TBL] [Abstract] [Full Text] [Related]
5. Association of polymorphisms and haplotype in the region of TRIT1, mycl1 and MFSD2A with the risk and clinicopathological features of gastric cancer in a southeast Chinese population.
Chen S; Zheng Z; Tang J; Lin X; Wang X; Lin J
Carcinogenesis; 2013 May; 34(5):1018-24. PubMed ID: 23349019
[TBL] [Abstract] [Full Text] [Related]
6. Association between restriction fragment length polymorphism of the L-myc gene and susceptibility to gastric cancer.
Shibuta K; Mori M; Haraguchi M; Yoshikawa K; Ueo H; Akiyoshi T
Br J Surg; 1998 May; 85(5):681-4. PubMed ID: 9635822
[TBL] [Abstract] [Full Text] [Related]
